Navigation Links
Upsher-Smith Announces New Formulation of PreNexa(R) Prenatal Vitamins

MAPLE GROVE, Minn., Feb. 2 /PRNewswire/ -- Upsher-Smith Laboratories, Inc. is pleased to announce the introduction of a new formulation of PreNexa® Rx prenatal vitamins.  The new formulation contains an increased amount of algal-oil, plant-based docosahexaenoic acid (DHA), from 265 mg to 300 mg and increased vitamin D3, from 170 IU to 400 IU.(1)

DHA, a key omega-3 fatty acid used throughout the body, helps support fetal and infant brain and eye development.(2,3) Vitamin D is an essential vitamin for mom's and baby's skeletal health.(4)

"PreNexa® is the fastest growing single-capsule prenatal vitamin with plant-based DHA on the market.  This new formulation reflects the increasing body of evidence pointing to the important role DHA and vitamin D play in pregnancy, lactation and infancy," said Wesley Mark Todd, MD, Senior Director Medical Affairs, Upsher-Smith Laboratories, Inc.  

The NDC number for the new formulation of PreNexa® is 0245-0177-30.  Key product features remain the same, including: the bottle configuration, amount per bottle (30 gel capsules), look of the gel capsule, and regimen of one pill once daily.  

Important Safety Information

Please see full Prescribing Information for a complete list of warnings and precautions. Warning: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under six.  KEEP THIS PRODUCT OUT OF REACH OF CHILDREN.  In case of accidental overdose, call a doctor or poison control center immediately.

About Upsher-Smith

Upsher-Smith Laboratories, Inc. is a rapidly growing pharmaceutical company that manufactures and markets both prescription and consumer products.  Privately held since 1919, the company strives to recognize the unmet healthcare needs of its customers.  Upsher-Smith prides itself on providing safe, effective, and economical therapies to the ever-challenged healthcare environment.  For additional information about PreNexa®, visit, or to learn more about Upsher-Smith, visit


(1) PreNexa (package insert).  Minneapolis, MN: Upsher-Smith Laboratories, Inc; 2010.

(2) Medline Plus.  Accessed September 9, 2008.

(3) Koletzko, et al.  The roles of long-chain polyunsaturated fatty acids in pregnancy, lactation and infancy; review of current knowledge and consensus recommendations.  J Perinat Med 36 (2008)5-14.

(4) Mulligan ML, Felton SK, Riek AE, et al. Implications of vitamin D deficiency in pregnancy and lactation. Am J Obstet Gynecol 2009;201.

SOURCE Upsher-Smith Laboratories, Inc.



SOURCE Upsher-Smith Laboratories, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Upsher-Smith Announces Milestone in Development of CNS Strategy
2. New Data: Cholesterol Management Analysis of Upsher-Smiths Slo-Niacin(R) Tablets in Combination with Lipitor(R)
3. Soligenix Announces Publication of Positive Stability Results with RiVax(TM), its Vaccine Against Ricin Toxin
4. ISTA Pharmaceuticals Announces Preliminary, Unaudited Revenue of $110.6 Million in 2009
5. CareFusion Announces 5-Year, Sole Source Pyxis(R) Perioperative Solutions Agreement With CHRISTUS Health
6. BIA Announces Release of Solis(TM) Integrated ESI Management and E-Discovery Platform
7. Pioneer(R) Surgical Technology, Inc. Announces New Expansion Plan
8. Cardica Announces Fiscal 2010 Second Quarter Financial Results
9. Sequenom Announces Addition to Clinical Advisory Board
10. Omnicell Announces Fourth Quarter and Full-Year 2009 Results
11. Life Spine(R) Announces FDA Clearance of DYNA-LINK(R) Spinal System and PRESIDIO(TM) Spinal Plating System
Post Your Comments:
(Date:11/26/2015)... 26, 2015 --> ... SyMRI to find optimal contrast weighting of MRI for ... has signed a research agreement with SyntheticMR in order to ... SyMRI, it is possible to generate multiple contrast images from ... patient has left, thus making it possible to both fine ...
(Date:11/26/2015)... 3D bioprinting market is expected to reach ... by Grand View Research Inc. Rising prevalence of chronic diseases ... is expected to boost the market growth, as 3D bioprinting ... --> 3D bioprinting market is expected to reach ... by Grand View Research Inc. Rising prevalence of chronic diseases ...
(Date:11/26/2015)... DUBLIN , November 26, 2015 /PRNewswire/ ... the addition of the "2016 Future ... Drugs of Abuse Testing Market: Supplier Shares, ... report to their offering. --> ... of the "2016 Future Horizons and ...
Breaking Medicine Technology:
(Date:11/27/2015)... , ... November 27, 2015 , ... ... the well-respected Microsoft Dynamics SL User Group (MSDSLUG). Recognized as Microsoft’s official group ... group of Microsoft Dynamics SL software users, partners, industry experts and representatives. Intellitec ...
(Date:11/27/2015)... ... November 27, 2015 , ... The men ... prominent nonprofit healthcare organizations in the country. They have overseen financial turnarounds, shown ... helped advance the healthcare industry as a whole through their advocacy and professional ...
(Date:11/26/2015)... ... 26, 2015 , ... Inevitably when people think Thanksgiving, they also think Holiday ... the Black Friday and Cyber Monday massage chair sales to receive the ... and low to find the best massage chair deals, they can see all of ...
(Date:11/26/2015)... TX (PRWEB) , ... November 26, 2015 , ... PRMA ... On November 19, 2015, our surgeons performed their 6,000th free flap breast reconstruction surgery! ... “We wake up every day excited to rebuild lives and it’s an honor to ...
(Date:11/25/2015)... BROOK, Ill. (PRWEB) , ... November 25, 2015 ... ... larger and potentially more aggressive than those found on mammography, according to a ... MRI findings of additional cancers not seen on mammography may necessitate a change ...
Breaking Medicine News(10 mins):